Invitrogen™ ELISA human beta-2 TGF kit

Ref.: BL-RE-092415Manufacturer ref.: EHTGFB2X10 10 x 96 tests
€4,815.00 excl. VAT

Transforming growth factors (TGF) beta mediate many cell-cell interactions that occur during embryonic development. Three beta TGFs were identified in mammals. TGF beta 1, TGF beta 2 and TGF...

Accession number
P61812
Dose range
8.23 to 6.000 pg/ml
Sensitivity of the dosage
15 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Transforming growth factors (TGF) beta mediate many cell-cell interactions that occur during embryonic development. Three beta TGFs were identified in mammals. TGF beta 1, TGF beta 2 and TGF...

Transforming growth factors (TGF) beta mediate many cell-cell interactions that occur during embryonic development. Three beta TGFs were identified in mammals. TGF beta 1, TGF beta 2 and TGF beta 3 are synthesized as very similar precursor proteins in that each is cleaved to produce a polypeptide of 112 amino acids that remains associated with the latent part of the molecule. Polypeptides of TGF beta are multifunctional; capable of influencing proliferation, differentiation and other cellular functions across a wide range of cell types. Processed tissues, as well as non-neoplastic tissues, release transformant growth factors; almost all mammalian cells have a specific TGF receptor. The multimodal nature of TGF beta is considered in its ability to stimulate or inhibit cell proliferation. In general, cells of mesenchymatous origin appear to be stimulated by beta TGF while cells of epithelial or neuroectodermal origin are inhibited by the peptide. TGF beta 1, TGF beta 2 and TGF beta 1.2 appear to be equivalent in terms of biological activity, although there appears to be differences in binding with certain receptor types. TGF beta 2 is produced by many cell types and has been found to be the highest concentration in porcine platelets and mammalian bones. The latent beta 2 TGF is the dominant isoform found in body fluids such as amniotic fluid, breast milk, and the aqueous and glassy mood of the eye.

Sensitivity

Sensitivity of dosage: 15 pg/ml.

Measurement range

Dose range: 8.23 to 6.000 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Coefficient of intradose variation < 10%, interdose < 12%.

Target

Target: TGF beta-2.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17788023
Specifications
Accession numberP61812
Dose range8.23 to 6.000 pg/ml
Sensitivity of the dosage15 pg/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)7042
Gene symbol(s)TGFB2
Coefficient of inter-dose variation< 12%
Coefficient of intra-dose variation< 10%
Contents of kits96-well pre-coated plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity10 x 96 tests
Regulatory statusRUO
TargetTGF beta-2
Test time1 h 20 min
Physical characteristics
Volume of samplePlasma, 62.5 μl-Serum, 62.5 μl-Surnatant, 62.5 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EHTGFB2X10
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.